Abstract
Healthcare, and the world at large, are currently facing an antibiotic crisis caused by the increase in antibiotic resistant bacterial pathogens, combined with divestment in the drug discovery pipeline for new antibiotics. The Tiny Earth Project is a global, student-driven, effort aimed at discovering and isolating new sources of antibiotics from soil microbes that can be used to combat multi-drug resistant bacterial pathogens. This study characterizes the antimicrobial and biochemical properties of three unique bacterial soil isolates from the genera Janthinobacterium , Pseudomonas , and Pseudoclavibacter and their extracted secondary metabolites.